To learn more about IGALMI, visit www.igalmi.com
Please click here for full Prescribing Information:
Prescribing Information
Intended for U.S. residents only
IGALMI is a registered trademark of BioXcel Therapeutics, Inc.
All other trademarks are the properties of their respective owners.
Copyright © 2025 BioXcel Therapeutics Inc. All Rights Reserved. US-IGA-2300177
IGALMI is a registered trademark of BioXcel Therapeutics, Inc.
All other trademarks are the properties of their respective owners.
Copyright © 2025 BioXcel Therapeutics Inc. All Rights Reserved. US-IGA-2300177
Job seekers should emphasize vigilance against unsolicited job offers, especially those received via text or email. It’s crucial to verify the legimacy of any job opportunity by independently researching the company and recruiter and by contacng the company directly using the informaon found on their official website, not the contact details provided in the unsolicited message. Legimate recruiters generally don’t iniate contact through unsolicited texts or emails and don’t use emojis in their messages. If you encounter a suspicious job offer, report it to the Federal Trade Commission (FTC) at ReportFraud.ftc.gov or the Internet Crime Complaint Center (IC3) at www.ic3.gov.
The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. This web site is intended to help healthcare professionals practicing in the US find scientifically balanced, evidence-based information about Bioxcel Therapeutics drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.